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Abstract
Background: The United States Public Health Service (USPHS) Guideline for Treating Tobacco Use and Dependence includes
ten key recommendations regarding the identification and the treatment of tobacco users seen in all health care settings.
To our knowledge, the impact of system-wide brief interventions with cigarette smokers on smoking prevalence and health
care utilization has not been examined using patient population-based data.
Methods and Findings: Data on clinical interventions with cigarette smokers were examined for primary care office visits of
104,639 patients at 17 Harvard Vanguard Medical Associates (HVMA) sites. An operational definition of ‘‘systems change’’
was developed. It included thresholds for intervention frequency and sustainability. Twelve sites met the criteria. Five did
not. Decreases in self-reported smoking prevalence were 40% greater at sites that achieved systems change (13.6% vs. 9.7%,
p,.01). On average, the likelihood of quitting increased by 2.6% (p,0.05, 95% CI: 0.1%–4.6%) per occurrence of brief
intervention. For patients with a recent history of current smoking whose home site experienced systems change, the
likelihood of an office visit for smoking-related diagnoses decreased by 4.3% on an annualized basis after systems change
occurred (p,0.05, 95% CI: 0.5%–8.1%). There was no change in the likelihood of an office visit for smoking-related
diagnoses following systems change among non-smokers.
Conclusions: The clinical practice data from HVMA suggest that a systems approach can lead to significant reductions in
smoking prevalence and the rate of office visits for smoking-related diseases. Most comprehensive tobacco intervention
strategies focus on the provider or the tobacco user, but these results argue that health systems should be included as an
integral component of a comprehensive tobacco intervention strategy. The HVMA results also give us an indication of the
potential health impacts when meaningful use core tobacco measures are widely adopted.
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Introduction
The United States Public Health Service (USPHS) Guideline
for Treating Tobacco Use and Dependence includes ten key
recommendations regarding the identification and the treatment
of tobacco users seen in all health care settings [1]. While there is
significant research from randomized clinical trials to support the
impact of brief tobacco interventions [2,3,4], the USPHS
Guideline also states that ‘‘it is imperative that new research
examine the implication of effective treatments in real-world
settings.’’ With the implementation of the Patient Protection and
Affordable Care Act (PPACA) and the rapid adoption of
meaningful use (MU) compliant software [5] for electronic health
records (EHR), it should be possible to use data collected in these
real-world settings to measure the health and economic impact of
brief tobacco interventions.
While research clearly shows that systems-level changes can
reduce smoking prevalence among enrollees of managed health
care plans [6,7,8], comparable research has yet to emerge from the
healthcare delivery system. To date and to our knowledge, there is
little quantitative evidence from these real world settings to
support the link between the systematic delivery of brief tobacco
interventions, behavioral changes, and subsequent health im-
provements. However, with the volume of data available from
electronic health records, we hypothesized that there would be
sufficient data to demonstrate that routine clinical interventions
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reductions in office visits for smoking related diagnoses.
Methods
Setting
This study took place at Harvard Vanguard Medical Associates,
a large health care provider network based in eastern Massachu-
setts. HVMA has more than 20 offices primarily in Boston and the
surrounding suburban areas providing primary and specialty
health care to more than 400,000 patients. In 2007, HVMA
leadership established a clinical quality goal ‘‘to intervene’’ with
patients who smoke. A multidisciplinary design team comprised of
clinical and administrative personnel, defined ‘‘intervention’’ as
identification of cigarette smokers at every office visit and delivery
of a brief intervention to each identified smoker during that office
visit. HVMA used a team approach to complete the equivalent of
the PHS Guideline recommended ‘‘5A’’ tobacco intervention
(Ask, Advise, Assess, Assist, and Arrange). There are many
international correlates to the 5A model. For example, the
National Health Service Stop Smoking program in the United
Kingdom recommends a 4A model (i.e., Ask, Advise, Assist, and
Arrange follow up). In New Zealand, the system is titled ABC
which stands for Ask, Brief advice, and Cessation support. What
all these models have in common is that the recommended
physician interventions are brief (,10 minutes) and that they
include offers of counseling as well as prescriptions for tobacco
cessation medications.
The data recorded at HVMA focused exclusively on cigarette
smokers instead of the broader definition of tobacco users. See
Figure 1 for the HVMA work flow for identifying cigarette
smokers.
In this work flow, the medical assistant was charged with
recording in the EHR smoking status during each office visit and
to assess readiness to quit. The clinician was responsible for
advising each smoker to stop and for assisting each smoker
according to his/her stage of change. Decision support tools for
clinicians were embedded into the EHR to promote use of
evidence-based medications to strengthen quit attempts. An option
to refer smokers to a community-based, state-funded ‘‘stop-
smoking service’’ that provides free telephone counseling could
be ordered through the EHR. Advance Practice Clinicians (Nurse
Practitioners and Physician Assistants) were trained to provide
counseling and were educated on the use of stop-smoking
medications. Many intervention sites identified a tobacco cham-
pion to lead the work locally. Feedback reports of medical assistant
performance were delivered to clinical staff and administrative
supervisors monthly.
Data
De-identified encounter level data for all primary care office
visits for all adult patients at 17 HVMA sites was prepared by
analysts from Harvard Vanguard Medical Associates (HVMA).
Records covered the period from 1/1/2005 through 11/30/2010.
Evaluation plans were reviewed and approved by the Institutional
Review Board for the Massachusetts Department of Public Health.
Harvard Vanguard obtains written consent from patients for the
type of analysis conducted here. The consent form includes the
following 2 statements.
1) Harvard Vanguard may use or disclose your Health
Information in order to conduct its business of providing
health care. These ‘‘health care operations’’ may include
quality assessment, training of medical students, credentialing
and various other activities that are necessary to run our
practice and to improve the quality and cost effectiveness of
the care that we deliver to you. Some of these activities occur
in conjunction and cooperation with other Atrius Health
groups. Other of these business operations may be performed
by outside parties (‘‘Business Associates’’) on Harvard
Vanguard’s behalf. Our Business Associates must agree to
maintain the confidentiality of your Health Information.
2) Harvard Vanguard may disclose your Health Information for
public health activities.
The legal Department at Harvard Vanguard carefully reviewed
this project and determined that the analysis fell within the realm
of public health work related to quality improvement.
The de-identified data set prepared by HVMA analysts
contained demographics and encounter level data for 310,577
adult patients. Demographics for each patient included a randomly
defined patient ID, age, race/ethnicity, marital status, town of
residence, and patient’s ‘‘home’’ clinic site. All HVMA patients
have a ‘‘home site’’ which is the location of their primary care
provider. Since patients can change doctors and/or move from
one home site to another, the ‘‘home’’ for this data set was the
clinic site associated with the patient’s primary care provider on
11/30/2010. Data for all office visits at 17 HVMA office sites
between 1/3/2005 and 11/30/2010 also were prepared. Included
in the office visit encounter data were the unique patient ID,
a primary and four secondary diagnoses, and recorded compo-
nents of the brief intervention with cigarette smokers. For the
310,577 unique patients, there were 2,561,782 unique single-day
patient encounters in the data set prepared by HVMA analysts.
Nearly all (96.6%) interventions with cigarette smokers occurred at
a patient’s home site.
To be included in our analysis, patients had to be Massachusetts
residents between the ages of 22 and 64 on 11/30/2010, who were
screened for smoking status at least once. At least 3 years had to
elapse between the first and last office visit. The requirement that
patients be at least 22 years of age by 11/30/2010 was to ensure
that all patients in our data set were at least 18 when the first
HVMA site began to systematically intervene with cigarette
smokers (1/1/2007). Although some children were screened for
smoking status by HVMA, the intervention program for cigarette
smokers was aimed almost exclusively at adults. The upper age
limit was set to 64 because it was thought that older patients might
be receiving a greater proportion of their care outside the primary
care system. Seasonal residents and college students might also
receive care outside the primary care system, but it was impossible
to screen only for full-time/non-college residents with the data
available.
In the original data set, 104,639 of the 310,377 patients met the
criteria described above. Of this total, 15,286 had some history of
self-reported smoking recorded in the EHR between 1/3/2005
and 11/30/2010 while 89,353 had no recorded history of current
smoking in that time.
When recorded, smoking status was listed as either ‘‘Yes’’,
‘‘Quit’’, ‘‘Never’’, ‘‘Passive’’ or ‘‘Not Asked.’’ Since the ‘‘Passive’’
and ‘‘Not Asked’’ categorizations could not be used to specifically
define a patient’s use of cigarettes, these categories were ignored.
Therefore, smoker identification for this study was defined as an
office visit where smoking status was listed as ‘‘Yes’’, ‘‘Quit’’, or
‘‘Never.’’
The recorded smoking status was attached to the dated office
visit. This date was not overwritten as is often the case when
smoking status is stored in a patient’s social history. As a result, the
full complement of patient encounter records would have
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addition to smoking status, information could be recorded about
a patient’s interest in quitting, readiness to quit, smoking pattern,
referrals to telephone counseling, and prescriptions for medica-
tions covered by insurance.
For this study, a brief intervention with smokers was defined as
any evidence at a specific visit that the conversation about
cigarette smoking went beyond the identification of smoking
status. This could include information about interest in quitting,
readiness to quit, smoking pattern, referrals to telephone
counseling, and prescriptions for medications covered by in-
surance. Therefore, any visit in which a patient was identified as
a smoker could also include a brief intervention about smoking.
Assessing Data Quality
To assess data quality, we focused on all office visits throughout
the data set where a patient’s smoking status was recorded as
‘‘Never.’’ Of the three primary categories of smoking status (i.e.,
‘‘Yes’’, ‘‘Quit’’, and ‘‘Never’’), ‘‘Never’’ is the only absolute
classification. Logically, no visit where status is recorded as
‘‘Never’’ should have any other status recorded at a prior visit. To
obtain our quality assessment score, we counted the number of
times that the smoking status was also recorded as ‘‘Never’’ where
smoking status was also recorded at an earlier visit. Next, we
computed the percentage of the earlier visits in which smoking
status was also recorded as ‘‘Never.’’ For the 384,338 visits at
which smoking status was recorded as ‘‘Never’’, 381,917 (99.4%)
also had smoking status recorded as ‘‘Never’’ at the earlier visit.
Establishing the Date for Systems Change and Defining
Impact
To our knowledge there is no common standard for defining
systems change using real-world office encounter records. Oper-
ationally, we defined ‘‘health systems change’’ as first month when
more than half of all office visits at a given site included an
identification for cigarette smoking. In all months following that
date, the rate of cigarette smoker identifications could never drop
below 50%. Furthermore, there had to be at least 12 consecutive
months with rates above 50%. By this definition, 12 of the 17
HVMA sites had achieved ‘‘systems change.’’
Changes in self-reported smoking behavior were examined by
computing the proportion of all patients who were recorded as
smokers at the earliest possible visit and then comparing this to the
proportion of all patients recorded as smokers at the latest possible
visit. Group comparisons were made between sites that achieved
systems change and those that did not.
Changes in the rate of smoking-related office visits were
analyzed using generalized estimating equations (GEEs) with
a logistic link function and patient as the unit of analysis. The
period between 1/3/2005 and 11/30/2010 was divided into 77
twenty-eight day segments for 104,639 patients –15,286 patients
with histories of recent smoking and 89,353 patients with no
recent history of self-reported smoking. The dependent variable
was the presence or absence of a smoking-related office visit
during the 28-day period. If any of the first five recorded ICD9
codes for any visit in a 28-day period matched the list of
smoking-related diagnoses from the Surgeon General’s 2004
Figure 1. Harvard Vanguard Medical Associates work flow for interventions with smokers.
doi:10.1371/journal.pone.0041649.g001
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All other periods were coded as 0.
To avoid biasing the results, data prior to and including the
period of the first recorded visit were not included in the analysis.
Patients were divided into those who had some history of self-
reported smoking between 1/5/2005 and 11/30/2010 and those
who had no history of self-reported smoking. Any patient who
reported current smoking at any visit between 1/5/2005 and 11/
30/2010 was grouped with the smokers. Longitudinal data for
smokers and non-smokers were evaluated separately.
There were three temporal variables in each model: time since
1/1/2005, time since the first recorded office visit, and time since
systems change occurred at the patient’s home site. This last
variable was the primary focus of our analysis. We hypothesized
that there would be decrease in the rate of smoking-related office
visits following systems change and that this effect would only be
seen in patients with a recent history of self-reported smoking.
Our model adjusted for the seasonality of office visits using sines
and cosines [10]. Since the number of office visits generally
increases during flu season, our model also included the
percentage of office visits for all patients seen in a specific 28-
day period in which a flu vaccine was given as well as the
percentage of all office visits in which influenza was among the 5
recorded diagnoses. The model included the cigarette tax rate
throughout the period as well as a binary variable for the
implementation of health insurance reform in Massachusetts (7/1/
2006). There were 2 tax increases between 1/5/2005 and 11/30/
2010. To adjust for the individual rate of office visits by patients,
the model included a term for the average number of visits for
a specific patient in all prior periods. Finally, we adjusted for
correlations among repeated office visits within patients across
time, assuming a first-order autoregressive structure. All analyses
were conducted using SAS 9.1 (SAS Corporation, Cary, North
Carolina).
Results
Rates of Identification and Brief Intervention Before and
after Systems Change
As defined above, ‘‘systems change’’ occurred at 12 of the 17
sites between 1/1/2007 and 4/1/2009. For all 12 sites, there was
a dramatic and significant increase in the identification rate of
cigarette smokers after the date of achieving systems change. All
but one site achieved an 80% identification rate within 9 months
of that date. The median time between the date of ‘‘systems
change’’ and an 80% identification rate was just 4.5 months. At 11
of the 12 sites, there was also a significant increase in the
percentage of rate of brief intervention for identified cigarette
smokers. Identification rates for the remaining 5 sites remained
relatively low throughout the study period. At sites that achieved
systems change, 82.5% of visits where patients were identified as
smokers included evidence of a further clinical intervention. At
sites that did not achieve systems change, this rate was only 59.4%.
Table 1 presents pre-post identification and intervention rates at
the 17 HVMA sites.
The proportion of home-site interventions was slightly higher
for patients seen at the 12 sites where systems change took place
(97.2% versus 93.1%).
Demographics, Smoking Prevalence, and Office Visit
Statistics
Most demographics were similar for smokers and non-smokers.
However, patients with a recent history of self-reported smoking
were more likely to be younger, male, of white race and live alone.
Smokers had a significantly higher average number of office visits
(Table 2).
Changes in smoking prevalence were examined by focusing on
patient visits where smoking status was recorded. Of the 104,639
patients in our study group, 13,517 (12.9%) were current smokers
at the first visit where smoking status was recorded. On the last
visit where smoking status was recorded, 11,817 (11.3%) were
current smokers. Overall, there were 1,700 (12.6%) fewer smokers
at the last visit. The decrease in self-reported smoking prevalence
was 40% larger at the 12 sites that achieved systems change
(13.6% vs. 9.7%, p,.01). As one would expect given our
operational definition of systems change, patients received more
clinical interventions about cigarette smoking at sites that achieved
systems change (5.3 vs. 2.6, p,0.001).
The impact per encounter of brief clinical intervention on the
likelihood of quitting was examined using a logistic model. The
outcome variable was the final recorded smoking status for
a patient (i.e., Yes=1, Quit=0). The model included as
predictors the total number of office visits where the patient’s
smoking status was recorded and the number of office visits
where smoking status was not recorded. The analysis was
restricted to 1,255 patients who had at least 4 years of between
the first and last visit, at least 3 years between the first and last
confirmation, and at least one visit in which smoking status was
recorded as ‘‘Yes.’’ Each encounter where a smoker’s smoking
status was recorded increased the likelihood of quitting by 2.6%
(p,0.05, 95% CI: 0.1%–4.6%).
Decreasing Likelihood of Smoking-Related Office Visits
for Smokers
Most office visits did not include a smoking-related diagnosis
code. On average, smokers had 0.90 smoking related office visits
throughout the time period studied while non-smokers had an
average of 0.69 visits with a smoking-related diagnosis code.
Changes in the rate of smoking-related office visits were computed
using generalized estimating equations (GEEs). Separate models
were developed for patients with recent histories of self-reported
smoking and all other patients. We refer to these groups as
smokers and non-smokers. The independent variable of primary
interest was the time since systems change occurred at the patient’s
home site.
After adjusting for temporal effects, seasonality, previous visit
pattern, flu-related visits, the date of health reform, and cigarette
taxes, the annualized rate of smoking-related office visits
following systems change for smokers decreased by 4.3% (95%
CI: 0.5%–8.1%). The difference from the unadjusted to the
adjusted rates is likely due to the fact that several of the
independent variables had strong positive relationships with the
dependent variables (e.g., age, gender, average number of office
visits, and flu-related visits). For non-smokers, there was a non-
significant decrease (0.8%, p=0.37) in the annualized rate of
smoking-related office visits following systems change (95% CI:
20.4% to 2.0%). See Table 3.
To explore whether demographics could explain the re-
duction in the rate of smoking related office visits, six primary
and interaction terms were added to the smoker and non-
smoker models. The primary terms were the six demographic
variables shown in Table 2 (i.e., Gender, Single, Married, White
non-Hispanic, Black non-Hispanic, and Hispanic). The interac-
tions were these demographics in conjunction with the time
since systems change occurred at a patient’s home site. Of
particular interest were the interaction terms. For both models,
the only interaction term reaching significance was the time
since systems change and whether a patient was married.
Systematic Clinical Interventions and Smoking
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in the likelihood that a married patient visited the doctor for
a smoking related condition increased slightly. The reason for
this effect is not clear. That said, the addition of these
interaction terms did not appreciably change the main effects
seen for systems change in either model. For smokers, there was
still a significant decrease in the likelihood of a smoking related
office visit following systems change at the home site. For non-
smokers, there was no effect.
Discussion
Summary of Results
An operational definition of systems change was established for
clinical interventions with cigarette smokers. This definition
included thresholds for frequency and sustainability. Based on
this definition, 12 of 17 HVMA sites achieved systems change
between 1/1/2007 and 12/1/2009. These 12 sites had significant
increases in rates of smoker identifications and further clinical
Table 1. Identification and intervention rate by site before and after ‘‘systems change’’.
Before Systems Change After Systems Change
Site
Date of
‘‘Systems
Change’’ Total Visits Identification Rate
Brief Intervention
Rate Total Visits Identification Rate
Brief Intervention
Rate
Site 1 Jan-07 20,638 21% 50% 84,438 91% 84%
Site 2 May-07 47,651 3% 57% 77,419 93% 94%
Site 3 Jun-07 64,552 3% 43% 102,194 94% 91%
Site 4 Jul-07 88,015 12% 75% 126,955 88% 84%
Site 5 Oct-07 1,906 31% 47% 2,777 79% 63%
Site 6 Jun-08 69,262 13% 70% 73,054 87% 88%
Site 7 Jul-08 157,212 14% 64% 129,824 93% 89%
Site 8 Aug-08 93,455 9% 57% 65,491 91% 91%
Site 9 Oct-08 62,736 9% 72% 41,214 81% 84%
Site 10 Feb-09 130,338 20% 67% 74,421 92% 92%
Site 11 Mar-09 33,210 18% 47% 19,588 64% 57%
Site 12 Apr-09 76,866 13% 59% 36,504 87% 88%
Site 13 N/A 255,254 34% 61% N/A N/A N/A
Site 14 N/A 134,036 25% 54% N/A N/A N/A
Site 15 N/A 167,814 21% 63% N/A N/A N/A
Site 16 N/A 44,878 15% 68% N/A N/A N/A
Site 17 N/A 280,080 11% 51% N/A N/A N/A
doi:10.1371/journal.pone.0041649.t001
Table 2. Demographics and office visit statistics by smoking status.
All Patients
(n=104,639)
Smokers
(n=15,286)
Non-Smokers
(n=89,353)
Criteria*
Smoking status recorded between
1/5/05 and 11/30/10.
Evidence of current smoking
between 1/5/05 and 11/30/10.
No evidence of current smoking
between 1/5/05 and 11/30/10.
Average age in years 46.5 45.3 46.8
% Female 61.1% 58.0% 61.6%
% Single 20.0% 25.5% 19.0%
% Married 47.9% 35.3% 50.1%
% White non-Hispanic 68.0% 72.0% 67.3%
% Black non-Hispanic 12.5% 12.4% 12.5%
% Hispanic 4.1% 3.8% 4.2%
Average number of office
visits
11.9 13.3 11.7
Average time between first
and last visit
4.6 years 4.7 years 4.6 years
*Full inclusion criteria required that patients be Massachusetts residents between the age of 22 and 64 on 11/30/2010, screened for smoking status at least once, with at
least 3 years between the first and last office visit.
doi:10.1371/journal.pone.0041649.t002
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found across all sites; however, the reduction in prevalence was
40% greater at sites achieving systems change. We estimate that
each clinical intervention with a smoker increased the likelihood of
quitting by 2.4%. The likelihood of an office visit for a smoking-
related diagnosis also decreased but only for smokers at sites that
achieved systems change (4.3%). Among non-smokers, there was
no significant change in the rate of office visits for smoking-related
office visits following systems change. Patient demographics did
not appear to strongly affect the likelihood of a smoking related
office visit following systems change.
Implications
The health care system should be viewed as central to the any
tobacco intervention strategy. As recommended in the USPH
Guideline, health care administrators like practice managers and
chief medical officers, as much as individual clinicians, must be
responsible for ensuring that tobacco interventions become an
integrated component of health care delivery. Yet, despite the
well-known consequences of tobacco use and conclusive research
on the effectiveness of tobacco treatment, many healthcare
facilities still lack the policies and clinical systems needed to
achieve consistent and effective treatment. However, this land-
scape is changing rapidly. Recent federal legislation, including
PPACA, ARRA (American Recovery and Reinvestment), and
HITECH (Health Information Technology for Economic and
Clinical Health) include provisions that incentivize physician
providers and hospitals increasingly to identify tobacco users,
assess use, and conduct interventions [11,12]. Chief among them
are CMS incentives to achieve the meaningful use of electronic
health records which includes identification of smokers as a core
measure.
The HVMA data support and shine the spotlight on strategies
in healthcare that focus on the system, rather than the individual
clinician. In the case with HVMA, data captured in the EHR is
retrieved and reported back monthly. Administrators and
clinicians (including physicians, nurse practitioners, physician
assistant, and medical assistants) are informed about their own
performance with comparisons to other sites. This analysis also
demonstrates that data sharing with clinicians may go beyond the
rate of brief tobacco interventions and enter the realm of
behavioral change and improvements of patient population health.
In contrast to strategies that target only the clinician or the
tobacco user, with systems strategies, tobacco use interventions are
likely to become a fully integrated and routine part of patient care.
Bolstered increasingly by meaningful use of EHRs, they may
become easier to perform than not. If results such as those realized
within HVMA can be replicated across the primary care delivery
system, significant strides can be made towards reducing tobacco
use prevalence and improving health.
Limitations
A number of limitations should be noted. Although we
endeavored to assess data quality, no independent measure of
quality was available and thus the inaccuracy of the electronic
medical records may lead to variability as well as potential bias in
the analysis. The size of this potential issue cannot be known.
However, our test of internal consistency showed that patients who
were recorded as never having smoked were also listed as never
smokers 99.7% of the time at prior visits. Furthermore, the sites
that had increased rates of brief intervention also had simultaneous
decreases in the number of smokers and the likelihood of office
visits for smokers. This is consistent with literature showing
relationships between likelihood of quitting and tobacco use
interventions with medical doctors. Had the data quality been
poor, it is unlikely that this relationship would have existed in the
HVMA patient histories.
This analysis also relied on patient self-report smoking status
that is subject to reporting bias, especially among certain
populations like pregnant women. The self-report bias may have
affected the estimates of smoking prevalence, but unlikely to have
affected the estimates of pre-post changes. The percentage of
women with ICD9 diagnosis codes (V22) for pregnancies varied
across sites from 2% to 5%. There was no discernible pattern
between these percentages and sites that achieved systems change.
Without any measure of continuity of care, we also can’t know
whether patients visited non-HVMA providers for any period of
time. We attempted to deal with the limitation by requiring that at
least 3 years elapse between the first and last visit for all patients in
our study group. We have no reason to assume that patients who
Table 3. GEE parameter estimates of percent change for smoking-related office visit in period: smoker and non-smoker models.
Smokers *
(n=15,286)
Non-Smokers **
(n=89,353)
Variable Percent change and 95% CI
Temporal effect 21.8% (14.8% to 28.9%) 22.9% (19.8% to 25.6%)
Years since 1
st visit 10.9% (5.6% to 16.2%) 9.9% (8.3% to 11.5%)
Years since systems change 24.3% (28.1% to 20.5%) 20.8% (22.3 to 0.7%)
Before/After Health Reform 11.7% (22.7% to 7.5%) 6.4% (21.2% to 14.1%)
Seasonality 1 (sine) 0.2% (0.1% to 0.3%) 0.2% (0.1% to 0.3%)
Seasonality 1 (cosine) 20.3% (20.4% to 20.2%) 20.3% (20.4% to 20.2%)
Avg # visits in prior periods 1.5% (1.4% to 1.6%) 1.3% (1.27% to 1.33%)
Current Age 3.0% (2.7% to 3.3%) 2.0% (1.9% to 2.1%)
% of visits in period for flu vaccination 0.3% (0.27% to 0.38%) 0.4% (0.40% to 0.46%)
% of visits in period with flu diagnosis 0.1% (0.05% to 0.15%) 0.04% (0.02% to 0.06%)
Current per pack tax rate 20.34% (2.49% to 2.20%) 20.36% (2.44% to 2.28%)
*Evidence of current smoking between 1/5/05 and 11/30/10.
**No evidence of current smoking between 1/5/05 and 11/30/10.
doi:10.1371/journal.pone.0041649.t003
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receive care at HVMA would bias the results in any way.
Similarly, the likelihood of office visits for smoking-related
diagnoses could be impacted by patients seeing non-HVMA
providers for their care. Smokers, in particular, have more health
problems and may require care of specialists or more ED or
hospital visits for smoking-related diagnoses. Furthermore, there is
extensive literature on what has been called the ‘‘ill-quitter effect’’
or ‘‘quitting while sick’’ [13]. While these effects are certainly real,
we sought to limit their impact on our analysis by requiring that
the visit history for all patients be at least 3 years long and by
restricting our population to adults under 64. It was thought that
this specific group of patients would be more likely to obtain health
care through the HVMA primary care system. But the most
important argument countering this potential limitation is the fact
that reductions in office visits with smoking-related diagnoses were
found only for smokers and that these changes were a function of
the date established for health systems change. Non-smokers
showed no reduction in the likelihood of an office visit for
smoking-related diseases following systems change.
Future Directions
Future research in this area should also examine data sets
collected in settings other than the primary care setting. Without
a better understanding of changes in hospitalization rates, it would
be impossible to claim that there have been significant health
improvements or to develop adequate return on investment
estimates for brief tobacco intervention in real world settings.
Nonetheless, the success of the HVMA program of brief tobacco
use interventions demonstrates the value of system-wide adoption
of MU core tobacco measures. When systems routinely meet the
MU criteria, there will be real opportunities to improve healthcare
quality, among them tailored feedback systems to motivate
clinicians, new ways to identify and address health disparities,
and development of payment systems that tie bonuses to reliable
measures of improving population health.
The forces driving healthcare in the United States to adopt
a systems approach to tobacco interventions are quite large. These
include significant federal legislation (PPACA, ARRA, and
HITECH), tobacco related meaningful use rules, and the move
toward Accountable Care Organizations, Alternative Quality
Contracts, and Value Based Purchasing. With these tailwinds,
the rates of tobacco interventions in the United States are likely to
increase significantly in the coming years, ultimately leading to
substantial savings from the decreased utilization of health care
services related to tobacco use.
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